HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions.

AbstractBACKGROUND:
The Tn antigen (CD175) is an O-glycan expressed in various types of human adenocarcinomas, including colorectal cancer (CRC), though prior studies have relied heavily upon poorly characterized in-house generated antibodies and lectins. In this study, we explored Tn expression in CRC using ReBaGs6, a well-characterized recombinant murine antibody with high specificity for clustered Tn antigen.
METHODS:
Using well-defined monoclonal antibodies, expression patterns of Tn and sialylated Tn (STn) antigens were characterized by immunostaining in CRC, in matched peritumoral [transitional margin (TM)] mucosa, and in normal colonic mucosa distant from the tumor, as well as in adenomas. Vicia villosa agglutinin lectin was used to detect terminal GalNAc expression. Histo-scoring (H scoring) of staining was carried out, and pairwise comparisons of staining levels between tissue types were performed using paired samples Wilcoxon rank sum tests, with statistical significance set at 0.05.
RESULTS:
While minimal intracellular Tn staining was seen in normal mucosa, significantly higher expression was observed in both TM mucosa (p < 0.001) and adenocarcinoma (p < 0.001). This pattern was reflected to a lesser degree by STn expression in these tissue types. Interestingly, TM mucosa demonstrates a Tn expression level even higher than that of the adenocarcinoma itself (p = 0.019). Colorectal adenomas demonstrated greater Tn and STn expression relative to normal mucosa (p < 0.001 and p = 0.012, respectively).
CONCLUSIONS:
In summary, CRC is characterized by alterations in Tn/STn antigen expression in neoplastic epithelium as well as peritumoral benign mucosa. Tn/STn antigens are seldom expressed in normal mucosa. This suggests that TM mucosa, in addition to CRC itself, represents a source of glycoproteins rich in Tn that may offer future biomarker targets.
AuthorsGabrielle E Dombek, Ana Sofia Ore, Jane Cheng, Yasuyuki Matsumoto, Jonathan N Glickman, Aaron Fleishman, Jamie Heimburg-Molinaro, Vitaliy Y Poylin, Anne Fabrizio, Thomas Cataldo, Evangelos Messaris, Richard D Cummings
JournalBMC cancer (BMC Cancer) Vol. 22 Issue 1 Pg. 1281 (Dec 07 2022) ISSN: 1471-2407 [Electronic] England
PMID36476111 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Tn antigen
Topics
  • Humans
  • Animals
  • Mice
  • Statistics, Nonparametric
  • Colorectal Neoplasms
  • Adenoma

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: